BLTE Competitors & Alternatives
Compare Belite Bio Inc ADR with similar stocks in the same industry
Biotechnology
BLTE
Main Stock$159.91
Tradestie Score
53
Market Cap
$2.41B
Analyst Upside
+33.8%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$76.92
|
$6.68B | - | 66 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$111.27
|
$6.64B | - | 49 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$114.48
|
$6.38B | - | 46 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$20.96
|
$6.03B | - | 39 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$56.88
|
$6.02B | - | 41 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$206.21
|
$5.92B | - | 66 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$53.60
|
$5.80B | 18.9 | 45 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$340.67
|
$5.20B | 42.4 | 54 | Compare |
More BLTE Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry